Mesenchymal VEGFA induces aberrant differentiation in heterotopic ossification.
Charles HwangSimone MariniAmanda K HuberDavid M StepienMichael SorkinShawn LoderChase A PaganiJohn LiNoelle D VisserKaetlin VasquezMohamed A GaradaShuli LiJiajia XuChing-Yun HsuPaul B YuAaron W JamesYuji MishinaShailesh AgarwalJun Z LiBenjamin LeviPublished in: Bone research (2019)
Heterotopic ossification (HO) is a debilitating condition characterized by the pathologic formation of ectopic bone. HO occurs commonly following orthopedic surgeries, burns, and neurologic injuries. While surgical excision may provide palliation, the procedure is often burdened with significant intra-operative blood loss due to a more robust contribution of blood supply to the pathologic bone than to native bone. Based on these clinical observations, we set out to examine the role of vascular signaling in HO. Vascular endothelial growth factor A (VEGFA) has previously been shown to be a crucial pro-angiogenic and pro-osteogenic cue during normal bone development and homeostasis. Our findings, using a validated mouse model of HO, demonstrate that HO lesions are highly vascular, and that VEGFA is critical to ectopic bone formation, despite lacking a contribution of endothelial cells within the developing anlagen.
Keyphrases
- vascular endothelial growth factor
- bone mineral density
- endothelial cells
- pi k akt
- mouse model
- soft tissue
- bone loss
- bone regeneration
- bone marrow
- neoadjuvant chemotherapy
- mesenchymal stem cells
- stem cells
- postmenopausal women
- radiation therapy
- anti inflammatory
- cell proliferation
- body composition
- high glucose
- signaling pathway